Dr. Domenico Accili will be awarded a Certificate of Honor, US$150,000 and a Japanese objet d’art on March, 2021. The award ceremony will be held on March, 2022.

The Selection Committee highly recognized his extensive and groundbreaking contribution over years to many landmark discoveries especially the one elucidating the fundamental role of FOXO 1 in ubiquitous insulin biochemical signals in different organs, which is key to understanding molecular pathogenesis and treatment of type2 diabetes.

Dr. Domenico Accili was therefore selected a Prize winner of this year.

~ 2020 Selection Committee Members ~
Dr. Takashi Kadowaki (Chairman)
President, Toranomon Hospital
Dr. Nobuya Inagaki
Professor and Chairman
Department of Diabetes, Endocrinology and Nutrition
Kyoto University Graduate School of Medicine
Dr. Makoto Daimon
Professor, Department of Endocrinology and Metabolism
Hirosaki University Graduate School of Medicine
Dr. Philipp E. Scherer
Professor, Department of Internal Medicine
Gifford O. Touchstone Jr. and Randolph G. Touchstone
Distinguished Chair in Diabetes Research
Director, Touchstone Diabetes Center
The University of Texas Southwestern Medical Center
Prof. Sir Stephen O’Rahilly
Director, Wellcome Trust-MRC Institute of Metabolic Science-Metabolic Research Institute 　University of Cambridge
Head of Department of Clinical Biochemistry, University of Cambridge
Scientific Director, Cambridge NIHR Biomedical Research Centre
Honorary Consultant Physician, Addenbrooke’s Hospital, Cambridge